$6.07, Wow ! Solid RED on higher than avg vol already for this early in trading day.
Looks like a trip into the $5's again may be in the on-deck circle here.
Wow, the ole magic of the Nasdaq "uplist" just hasn't panned out much yet it seems? And the ole "article" has been out there long enough for any "big money investors" to have read it cover to cover at least a few times by now.
This stock apparently has bigger issues putting the down pressure on it still? Not sure what- just dilution and overhang? Or the OTC transfer perhaps takes more than a name change and a new logo before the "big money" buys into the new "story" and make over and all?
They pulled the offer but have yet to say how they're gonna fund this thing going forward, especially a large, expensive phase II trial. It seems like until that gets answered (big dilution or net, etc) - then this is just floating around with no anchor or hooks to grab into yet IMO.
Too much uncertainty and the markets hate uncertainty.
